LPa (Lipoprotein a): Understanding Your Risks and Trials
Approximately 20 percent of people live with a genetic risk factor for heart disease that diet and exercise cannot change. This factor is known as...
Hereditary Angioedema: Your Guide to Trial Readiness
Imagine planning a simple dinner with friends while secretly calculating the distance to the nearest emergency room. This is the quiet reality for...
Epilepsy Support: Is a Clinical Trial Right for You?
You sit in the quiet of a doctor's office while complex medical terms fill the air. You hear words like focal onset to describe seizures starting in...
Understanding CIDP: Is a Clinical Trial Right for You?
Over 37.2 percent of people living with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) are initially misdiagnosed with a different...
Understanding Rare Bleeding Disorder Clinical Trials: A Guide to Clarity and Choice
Choosing to join a clinical trial is rarely about the science alone. It's about how that science fits into your Tuesday morning or your child's...
ITP Clinical Trials: How to Find the Right Study for You
Choosing to explore a research study is not a sign that your current treatment has failed. It is a deliberate step toward understanding how new...
Navigating von Willebrand Disease Clinical Trials
It takes an average of six to ten years for a person to receive a von Willebrand disease diagnosis after their symptoms first appear. This long wait...
Acute Myeloid Leukaemia (AML): Navigation and Treatment
The American Cancer Society estimates that approximately 22,720 people will receive a diagnosis of leukemia (Acute myeloid leukaemia (AML) in the...